ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 80 filers reported holding ANTARES PHARMA INC in Q1 2015. The put-call ratio across all filers is 5.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $683,000 | +5.4% | 252,000 | 0.0% | 0.01% | 0.0% |
Q4 2014 | $648,000 | -25.5% | 252,000 | +29.6% | 0.01% | -53.3% |
Q4 2013 | $870,000 | -8.7% | 194,500 | -17.1% | 0.02% | -16.7% |
Q3 2013 | $953,000 | +24.6% | 234,700 | +27.6% | 0.02% | +20.0% |
Q2 2013 | $765,000 | – | 184,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JW Asset Management, LLC | 1,671,956 | $5,384,000 | 3.43% |
ARMISTICE CAPITAL, LLC | 5,700,000 | $18,354,000 | 2.34% |
Rubric Capital Management LP | 3,188,600 | $10,267,000 | 2.12% |
Broadfin Capital, LLC | 4,803,528 | $15,467,000 | 1.88% |
THOMPSON DAVIS & CO., INC. | 192,734 | $621,000 | 1.00% |
Asymmetry Capital Management, L.P. | 199,655 | $643,000 | 0.76% |
Perceptive Advisors | 4,267,253 | $13,741,000 | 0.69% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 946,987 | $3,049,000 | 0.21% |
Brown Advisory Securities, LLC | 275,000 | $886,000 | 0.20% |
EAM Investors, LLC | 251,619 | $810,000 | 0.13% |